Experts
    • Medical Oncology
    • Medical Oncology
    • Medical Physics
    • Medical Education
    • Leading teams
    • Health Policy
    • Founder
    • Nanomedicine
    • Medical Research
    • Translational Research
    Arnold O. Beckman Postdoctoral Fellow @ MIT, American Physician Scientists Association Founder, Rice Alumni in Medicine President
    Arnold O. Beckman Postdoctoral Fellow @ MIT, American Physician Scientists Association Founder, Rice Alumni in Medicine President

    Freddy T Nguyen, MD, PhD is pursuing a postdoc at the Massachusetts Institute of Technology. Dr. Nguyen completed his MD-PhD from the University of Illinois at Urbana-Champaign in the Department of Chemistry on the development of Optical Coherence Tomography and contrast agents for the assessment of breast cancer tumor margins and axillary lymph nodes. He was awarded a pre-doctoral fellowship from the Department of Defense's Congressional Directed Medical Research Program in Breast Cancer. Dr. Nguyen's research interests have always been at the intersection of biomedical optics and medicine during his time at Rice University, MIT, and University of Illinois. Dr. Nguyen is the founder of the American Physician Scientists Association (APSA) and has been a long-time supporter and advocate of the physician-scientist trainee and pathway. He has served as President and Chair of the Board of Directors for a number of years and is currently Chair Emeritus of APSA. He has served in a number of national leadership roles representing physician-scientist trainees nationally and internationally. In recognition for his efforts, he was awarded APSA's Director's Award by the American Physician Scientists Association, American Society for Clinical Investigation, and Association of American Physicians. He has represented fellow trainees by serving in a number of leadership roles such as the Associate Member Council of the American Association for Cancer Research, Council of Student Members of the American College of Physicians, and the Association of Professors of Medicine's Physician-Scientist Initiative. In recognition of his leadership, he received the American Medical Association Foundation Excellence in Medicine Leadership Award. In his spare time, he volunteers his time for his alma mater, Rice University, having previously served the Association of Rice Alumni's Board of Directors and currently serves as President of Rice Alumni in Medicine.

    • Internal Medicine
    • Radiology
    • innovative care delivery models
    • precision medicine
    • machine learning
    Resident at Massachusetts General Hospital and Board of Directors Member at American Physician Scientists Association
    Resident at Massachusetts General Hospital and Board of Directors Member at American Physician Scientists Association

    Dania Daye, MD, PhD completed an internal medicine internship at Brigham and Women’s Hospital and is currently pursuing radiology residency at Massachusetts General Hospital. Dr. Daye graduated from the University of Pennsylvania MD-PhD program, with election to Alpha Omega Alpha. She completed her PhD in Bioengineering as an HHMI-NIBIB Interfaces scholar. Her interests lie at the intersection of machine learning, precision medicine and innovative care delivery models.  Dr. Daye served as the 2012-2013 President of the American Physician Scientists Association and currently serves on the board of directors. 

    • Pediatrics
    • Edelstein Family Chair of Pediatric Allergy-Immunology/Professor of Pediatrics at National Jewish Health and University of Colorado School of Medicine

    Dr. Leung is Professor of Pediatrics at University of Colorado Denver School of Medicine. He attended the University of Chicago where he received his PhD in 1975 and a MD in 1977. He did a pediatric internship and residency at Boston Children's Hospital and was a Fellow in Allergy-Immunology at Boston Children's Hospital between 1979-1981. He subsequently joined the faculty at Harvard Medical School with appointments as Assistant Professor (1983) and Associate Professor (1987) in Pediatrics. Since 1989, Dr. Leung has been Head of Pediatric Allergy-Immunology at National Jewish Health. He is a past member of the Board of Directors of the American Academy of Allergy, Asthma and Immunology (AAAAI) as well as The American Board of Allergy and Immunology (ABAI). Since 1994, he has been Director of the NIH funded, University of Colorado Clinical and Translation Research Center Site at National Jewish Health. Between 1998-2015, he was Editor-in-Chief of The Journal of Allergy and Clinical Immunology, the most highly cited journal in its field. He is the current Executive Editor of The Annals of Allergy, Asthma and Immunology.

    Dr. Leung has an H-index of 112 and is the author of more than 600 publications and has received over 30 federally funded grants. In 1983, he received the NIH Young Investigator Research Award for research on allergic responses in atopic dermatitis; Between 1995-2005, he was the recipient of a ten year NIH /NHLBI MERIT Award for his work in Kawasaki Syndrome, and in 1997, he won the E. Mead Johnson Award for Outstanding Research in Pediatrics; In 2003, he received the WAO Scientific Achievement Award; in 2004, he was the recipient of The American Skin Association/SID Psoriasis Achievement Award for his work on the role of infection in inflammatory skin diseases; the Institute for Scientific Information (ISI) named him to their list of World’s Most Highly Cited Authors in Immunology (top 0.5% of cited articles in past 20 years) in 2006; In 2004-present, he was appointed Principal Investigator of a multi-medical center NIH/NIAID Atopic Dermatitis Research Network to study mechanisms underlying bacterial and viral infections in atopic dermatitis. In 2012, he was awarded the AAAAI Distinguished Service Award for his contributions as Editor-in-Chief of The Journal of Allergy and Clinical Immunology. In 2013, he was chosen to deliver the prestigious Robert A. Cooke Lectureship at the AAAAI Annual meeting commemorating its founder and adding to numerous named lectureships that Dr. Leung has presented. In 2015, he also named by US News and World Report as being amongst the top 1% of physicians. In 2015, he was honored with The NJH Kauvar Presidential Award. In 2016, the AAAAI voted to name a 2016 AAAAI Foundation Faculty Development Award in his honor, i.e. “The Dr. Donald Y. M. Leung/JACI & AAAAI Foundation Faculty Development Award. In 2018, he received the AAAAI Distinguished Scientist Award for his work in Atopic Dermatitis.

    • General Surgery
    • Physiology
    • Biochemistry
    • Obesity
    • Diabetes
    • Metabolism
    • Bariatric Surgery
    • Insulin Resistance
    • Endocrinology
    Metabolic and bariatric surgeon-scientist investigator at Vanderbilt University
    Metabolic and bariatric surgeon-scientist investigator at Vanderbilt University
    • Resident, General Surgery at Vanderbilt University Medical Center

    Vance L. Albaugh, MD, PhD, is a surgeon-scientist investigator and senior resident in general surgery at Vanderbilt University who has completed dedicated research training in metabolism and bariatric surgery within the Section of Surgical Sciences at Vanderbilt University Medical Center ("Mechanisms of Bile Acid Signaling and Metabolism following Gastric Bypass", F32DK103474). He works with the Metabolic & Bariatric Surgery Team at Vanderbilt to better understand the metabolic and hormonal changes associated with bariatric surgery, with an emphasis on the weight loss-independent effects on insulin sensitivity/diabetes, gastrointestinal tract hormonal signaling, and resolution of obesity/diabetes co-morbidities. As a surgeon-scientist trainee, he also has interests in graduate medical education, surgical innovation, biostatistical analysis and reproducible research.

    • Cardiovascular Disease
    • Deputy Director of Cardiology, Director of Non-Invasive Cardiac Imaging, and Head of the Heart Failure Clinic at St. Vincent's Hospital

    Associate Professor David Prior is Deputy Director of Cardiology, Director of Non-invasive Cardiac Imaging and Head of the Heart Failure Clinic at St Vincent’s Hospital, Melbourne. After training in cardiology at the Alfred Hospital, he completed a PhD in heart failure at the Baker Heart Research Institute and subsequently a cardiac imaging fellowship at the Cleveland Clinic Foundation, Ohio. He has worked at St Vincent’s Hospital since 2000 and also holds a position as Associate Professor at the University of Melbourne. Major clinical and research interests are in heart failure management, cardiac imaging, sports & exercise cardiology and pulmonary hypertension. He is particularly interested in early diagnosis of disease with the aim of early treatment to improve long term outcomes.

    • Dermatology
    • Cell and Molecular Biology
    • Autoimmunity
    Associate Director, University of Pennsylvania MSTP, Faculty Advisor, Association of Women Student MD-PhDs (AWSM)
    Associate Director, University of Pennsylvania MSTP, Faculty Advisor, Association of Women Student MD-PhDs (AWSM)

    Dr. Payne graduated from Stanford University in 1993 and received her MD and PhD (Molecular and Cellular Biology) from Washington University in 2001. She completed her internal medicine internship, dermatology residency, and postdoctoral fellowship at the University of Pennsylvania. She joined Penn’s faculty in 2006, where she is currently a tenured Associate Professor of Dermatology, Associate Director of the Medical Scientist Training Program, and faculty advisor for the Association of Women Student MD-PhDs (AWSM). Through these roles she has been active in the recruitment and retention of physician-scientists nationwide, including trainees and junior faculty. Dr. Payne’s clinical practice specializes in autoimmune blistering diseases. She is also active in teaching and mentoring medical students, graduate students, dermatology residents, and research fellows. Dr. Payne’s research interests are in autoimmunity and cell adhesion, specifically in the context of the autoantibody-mediated blistering disease pemphigus. Her research has focused on 3 major areas of investigation: cloning and characterization of B cell repertoires to understand how autoimmunity occurs in pemphigus, cell biologic studies to identify signaling pathways that modulate desmosomal cell adhesion, and patient-oriented research to develop better targeted therapies for disease. Dr. Payne has received several honors for her research, including the Albert M. Kligman Endowed Chair, the Charles and Daneen Stiefel Scholar Award in Autoimmune Diseases, a "Top 10" Clinical Research Forum Award, and election to the American Society for Clinical Investigation. 

    • Rheumatology
    Director, MSTP
    Director, MSTP
    Dr. Utz directs a lab of 10 scientists in the Department of Medicine, Division of Immunology at Stanford University School of Medicine. The Utz lab studies autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), scleroderma, myositis, primary biliary chirosis (PBC), Sjögren's disease, type I diabetes, vasculitis, multiple sclerosis (MS) and mixed connective tissue disease (MCTD). In addition to trying to better understand the pathogenic mechanisms involved in autoimmunity, the Utz lab is interested in developing bench-to-bedside technologies, including multiplexed diagnostics and therapeutics, for human autoimmune diseases. Professor Utz’s lab has been one of the most innovative in the invention of novel technologies including protein arrays, peptide arrays, HIT, lysate arrays and Intel arrays. He is Director of Stanford’s Autoimmunity Center of Excellence (ACE) and has extensive expertise in coordinating 8 different program project grants over the last 12 years. He is also a leader in educational initiatives. He was the first Chair of Education for FoCIS. He founded and directs the Stanford Institutes of Medicine Research (SIMR) Program for high school students, which has hosted over 600 students in labs over 15 years, including 83 selected from over 1,500 applicants in 2014. SIMR has been funded by educational grants from NIH, HHMI, CIRM, DDCF, industry, and philanthropy. He is Director of the Stanford MSTP and is responsible for a >$6M budget and expansion of the program from 81 students to 120 students by 2019. He has served on the Immunology Program Predoctoral Committee and has won teaching and mentoring awards from the Immunology PhD Program and the Department of Medicine. In the last 10 years he has trained 52 scientists; served on 55 PhD thesis committees in 3 Schools on campus; successfully graduated all 11 PhD students who trained in his lab; currently is PhD advisor for 2 PhD students and 2 MSTP students; and has trained or is training 19 postdoctoral fellows. Of his graduate students, scholars, and fellows, 12 are currently employed in industry and 10 are Assistant or Associate Professors at academic institutions.
    • Clinical Pathology
    • Colorectal Caner
    • Human Molecular Genetics
    • Molecular Genetic Pathology
    • colon cancer prevention research
    • Molecular pathology
    Molecular Pathologist at the University of Washington
    Molecular Pathologist at the University of Washington

    Dr. Pritchard is an Associate Professor and head of the genetics division of Laboratory Medicine, as well as the co-director of the genetics and solid tumors laboratory at the University of Washington Medical Center that services the Seattle Cancer Care Alliance (SCCA). He completed his graduate and medical training at the University of Washington School of Medicine. The Pritchard laboratory focuses on oncology molecular diagnostics, particularly the source and utility of cell-free nucleic acid biomarkers in blood, and the development of innovative molecular diagnostics for the identification of mutations that can guide risk- assessment and therapeutic decision making. His clinical work focuses on applications of next-generation sequencing gene panels for cancer risk assessment and precision treatment. He has led the development and implementation of multiple cancer gene panel tests that are in current clinical use for cancer patients and their families. For more details about Dr. Pritchard see: http://depts.washington.edu/labweb/Faculty/pritchardColin.htm http://www.seattlecca.org/doctor/colin-c-pritchard.cfm For more details about the UW-OncoPlex™ program for precision medicine see: http://www.seattlecca.org/diseases/oncoplex-precision-medicine.cfm

    • Clinical Pathology
    Associate Director, Pathology Residency Training Program, UAB
    Associate Director, Pathology Residency Training Program, UAB
    Dr. Lorenz received her B.S. in biology from Stanford University and her M.D. and Ph.D. in immunology from Washington University in St. Louis. She completed residency in Clinical Pathology at Barnes-Jewish Hospital, while also doing postdoctoral research in Gastrointestinal Biology at Washington University in St. Louis. She then joined the Washington University faculty as an Assistant Professor of Pathology and Medicine, where she also served as Medical Director of the Joint Clinical Immunology Laboratory for Barnes-Jewish and St. Louis Children’s Hospitals and Associate Director of the Laboratory Medicine Residency Training Program. Dr. Lorenz joined the UAB Department of Pathology in 2002. She is currently Associate Director of the Pathology Residency Training Program and Director of the Summer in Biomedical Sciences Undergraduate Research Program at UAB. Dr. Lorenz’s research focuses on the interaction between gastrointestinal mucosal cells and luminal antigens. A major topic of investigation is the cellular immune response to Helicobacter in a mouse model of gastric infection and inflammation. This infection results in life-long colonization and gastric inflammation and is involved in the pathogenesis of peptic ulcer disease, gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma. Her laboratory established the essential role of the adaptive immune response in Helicobacter-induced gastric pre-neoplastic lesions and is characterizing the T cell response generated to the bacterium. The second area of focus in her laboratory is the role of the intestinal epithelium and innate immune responses in the development of inflammatory bowel disease. We are investigating these interactions in a spontaneous model of colonic inflammation that occurs in the absence of the multidrug resistance protein 1a.
    • Gastroenterology
    • Internal Medicine

    Assoc. Dean, Physician Scientist Education and Training

    Professor of Medicine and Cancer Biology

    Director, Medical Scientist Training Program (MSTP)

    Associate Director, Physician Scientist Training Program (PSTP)

    Staff Physician, VA Health System

    Vanderbilt University School of Medicine

    1065D MRB-IV

    B2215 Garland Ave

    Nashville, TN 37232

    • Pediatrics
    • Pediatric Endocrinology
    • Advocacy
    • Medical Education Curriculum Development
    • Population and community health
    • Medical education technology
    Pediatric Endocrinologist
    Pediatric Endocrinologist
    • Associate Program Director, UCSF-Fresno Pediatric Residency Program; Medical Director, Pediatric Endocrinology, Associate Clinical Professor, UCSF-Fresno at UCSF-Fresno, Department of Pediatrics

    Dr. Renee Kinman is a pediatric endocrinologist, an Associate Clinical Professor at UCSF-Fresno, and an Associate Program Director for the UCSF-Fresno Pediatric Residency Program. Actively involved in medical education and curricular development, she enjoys working with medical students, residents and faculty, and is the recipient of multiple teaching awards. She completed the Teaching Scholars Program at UCSF, and is a member of both the UCSF Academy of Medical Educators and the UCSF Faculty Development Working Group, all of which are dedicated to improving medical education. She is active out in the community, is passionate about advocacy and education, and is the recipient of several grants to improve resident and medical student education in community pediatrics and advocacy by partnering with the local public school system and local universities. Board-certified in pediatrics, internal medicine, and pediatric endocrinology, she also has a PhD in physiology and biophysics in the area of insulin transport, and has completed her masters degree in Education in the area of Curricular Design and Instruction.  She is and is currently serving as a fellow in the a Champion Provider Fellowship Program, launched by the California Department of Public Health & the University of California, San Francisco in 2014 to empower, train, and support healthcare providers to use their expertise and respected voices to improve the health of communities through local policy, systems and environmental changes.  She also teaches figure skating in the local Skating School as part of her physician wellness.

    • Dermatology
    • Immunology
    Resident Physician, UPMC Department of Dermatology
    Resident Physician, UPMC Department of Dermatology
    • Resident Physician, Dermatology at UPMC

    Dr. Jackson is currently training in the dermatology residency program at the University of Pittsburgh Medical Center. She graduated from the Saint Louis University School of Medicine MD-PhD Program in May 2016, where she was awarded a PhD in Molecular Microbiology and Immunology.  Her training was supported by an individual F30 Ruth Kirschstein pre-doctoral award. She subsequently completed an internal medicine internship at Saint Louis University School of Medicine.  Her interests lie at the intersection of dermatology and immunology, with a focus on cutaneous oncology and autoimmune/inflammatory diseases. Her long-term research interests lie in the design, characterization, and translation of novel immunotherapeutics for patient benefit.  She has served in a variety of leadership capacities in the American Physician Scientists Association, notably as Vice President (2013-2014) and as Chair of the Partnerships Committee (2012-2014).

    • Internal Medicine
    • pharmacology
    • Director, Medical Scientist Training Program at University of California, San Diego

    Dr. Insel received his M.D. from the University of Michigan and subsequent clinical training on the Harvard Medical Service at Boston City Hospital. He then began research training/efforts at NIH in the NICHD Gerontology Research Center and the NCI Laboratory of Theoretical Biology and subsequently at UCSF in the Cardiovascular Research Institute and Depts. of Medicine and Pharmacology. He joined the UCSF faculty as Assistant Professor-in-residence in the Dept. of Medicine and then moved as an Assistant Professor to the Division of Pharmacology, Dept. of Medicine at UCSD, where he is currently Distinguished Professor of Pharmacology and  Medicine at UCSD. Since 1989, he has been the Director of the UCSD Medical Scientist (M.D./Ph.D.) Training Program. Dr. Insel has been actively involved in the National Association of M.D/Ph.D Programs, serving as its inaugural President. He holds a Doc. Hon Causa from the University of Paris and is a Fellow, American Association for the Advancement of Science. Dr. Insel has served as Associate Editor and Editor of numerous scientific journals. He is currently Editor of the Annual Review of Pharmacology and Toxicology and co-Head of Faculty of the Faculty of 1000Prime in Pharmacology and Drug Discovery Dr. Insel’s research efforts have focused on studies of G-protein-coupled receptors (GPCRs) with respect to their expression, signaling mechanisms, regulation, effects in target cells and roles in health and disease through the use of biochemical, cell and molecular biological approaches. Studies have emphasized heterotrimeric G-proteins, G-protein-regulated effectors, compartmentation of signaling entities in lipid raft/caveolin domains, cAMP-promoted responses and the use of “omics”  approaches to define GPCR expression and the cAMP-regulated transcriptome and proteome. Dr. Insel has published >280 original articles and >150 reviews, invited articles and book chapters.

    • Hematology

    Lawrence (Skip) Brass, MD PhD is a graduate of Harvard College and Case Western Reserve University, where he received his MD and a PhD in biochemistry. After residency training in internal medicine he became a fellow in Hematology-Oncology at the University of Pennsylvania where he served as Vice Chair for Research in the Department of Medicine from 2004 to 2007, and is currently Professor of Medicine and Professor of Systems Pharmacology and Translational Therapeutics. He has led the NHLBI-funded Hematology Research Training Program since 1994 and became Associate Dean for Combined Degree and Physician Scholars Programs and Director of Penn’s MSTP in 1998. He has been active at the national level in the development of training programs for physician-scientists, has served as President of the National Association of MD-PhD Programs, Chair of the AAMC GREAT section on MD-PhD training and was a member of the NIH Physician-Scientist Workforce advisory group in 2013-2014. He is also a practicing hematologist whose research interests are in the fields of hemostasis and vascular biology. He has been continuously funded by the NIH HLBI since the mid-1980’s, has been elected to the American Society for Clinical Investigation and the Association of American Physicians, was an Established Investigator of the American Heart Association and is a recipient of the Distinguished Career Award from the International Society of Hemostasis and Thrombosis, the Christian R. and Mary F. Lindback Award for Distinguished Teaching from the University of Pennsylvania, the inaugural Bert Shapiro Award for Leadership, Dedication and Service to the Physician-Scientist Community from the National Association of MD/PhD Programs, and numerous teaching awards from students at the Perelman School of Medicine.

    • Medical Oncology
    Team Leader at the Vall Hebron Institute of Oncology
    Team Leader at the Vall Hebron Institute of Oncology

    Joaquin Mateo is a physician-scientist and medical oncologist. He leads the Prostate Cancer Translational Research lab at Vall Hebron Institute of Oncology in Barcelona. After completing medical school and clinical training in Medical Oncology, he joined the The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research (London) in 2011, where he pursued his PhD in Prof. Johann de Bono´s laboratory, developing first-in-man clinical trials of several PARP inhibitors and compounds targeting the PI3K-AKT-mTOR pathway, with particular interest in developing novel therapies for prostate cancer patients in parallel to developing predictive biomarkers for a more genomics-tailored patient care. His main interest is the integration of tumor molecular characterisation data into real-time clinical decision-making for patients through multidisciplinary tumor boards.